Walleye Capital
INBS icon

Walleye Capital’s Intelligent Bio Solutions INBS Stock Holding History

Walleye Capital’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-801
Closed -$274K – 4566
2023
Q1 		$274K Buy
+801
New +$735K ﹤0.01% 2200

Other funds holding INBS

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Capital's INBS Position: Q2 2023 in Review

Walleye Capital sold out of Intelligent Bio Solutions (INBS) in Q2 2023, closing a stake of 801 shares — an estimated $274K sold.

Walleye Capital first reported a position in INBS in Q1 2023 and held it in 1 quarter. The position peaked at $274K in Q1 2023. 1 fund tracked by Wall St. Rank holds INBS as of Q2 2023.

  • Walleye Capital reported no remaining Intelligent Bio Solutions position as of Q2 2023 after selling out during the quarter.
  • Walleye Capital sold 801 Intelligent Bio Solutions shares in Q2 2023, an estimated $274K.
  • Walleye Capital first reported a position in Intelligent Bio Solutions in Q1 2023 and held it in 1 quarter.
  • Walleye Capital's Intelligent Bio Solutions position peaked at $274K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.